Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

AstraZeneca

Status: Completed

Conditions: Asthma

Treatments: Drug: Symbicort

Study type: Observational

Funder types: Industry

Identifiers

NCT00573222

NIS-RHR-SYM-2007/1

Details and patient eligibility

About

This is a 3-month non-interventional, observational study on patients with moderate and severe asthma.

Enrollment: 330 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with moderate and severe asthma on Symbicort SMART treatment

Exclusion criteria

• Under 18 years old